Global Thrombin Market Insights and Forecast to 2028

Global Thrombin Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Thrombin Product Introduction
1.2 Market by Type
1.2.1 Global Thrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Powder Form
1.2.3 Solution Form
1.2.4 Pad Form
1.2.5 Spray Kits
1.2.6 Others
1.3 Market by Application
1.3.1 Global Thrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Thrombin Sales Estimates and Forecasts 2017-2028
2.2 Global Thrombin Revenue Estimates and Forecasts 2017-2028
2.3 Global Thrombin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Thrombin Sales by Region
2.4.1 Global Thrombin Sales by Region (2017-2022)
2.4.2 Global Sales Thrombin by Region (2023-2028)
2.5 Global Thrombin Revenue by Region
2.5.1 Global Thrombin Revenue by Region (2017-2022)
2.5.2 Global Thrombin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Thrombin Sales by Manufacturers
3.1.1 Global Top Thrombin Manufacturers by Sales (2017-2022)
3.1.2 Global Thrombin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Thrombin in 2021
3.2 Global Thrombin Revenue by Manufacturers
3.2.1 Global Thrombin Revenue by Manufacturers (2017-2022)
3.2.2 Global Thrombin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Thrombin Revenue in 2021
3.3 Global Thrombin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Thrombin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Thrombin Sales by Type
4.1.1 Global Thrombin Historical Sales by Type (2017-2022)
4.1.2 Global Thrombin Forecasted Sales by Type (2023-2028)
4.1.3 Global Thrombin Sales Market Share by Type (2017-2028)
4.2 Global Thrombin Revenue by Type
4.2.1 Global Thrombin Historical Revenue by Type (2017-2022)
4.2.2 Global Thrombin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Thrombin Revenue Market Share by Type (2017-2028)
4.3 Global Thrombin Price by Type
4.3.1 Global Thrombin Price by Type (2017-2022)
4.3.2 Global Thrombin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Thrombin Sales by Application
5.1.1 Global Thrombin Historical Sales by Application (2017-2022)
5.1.2 Global Thrombin Forecasted Sales by Application (2023-2028)
5.1.3 Global Thrombin Sales Market Share by Application (2017-2028)
5.2 Global Thrombin Revenue by Application
5.2.1 Global Thrombin Historical Revenue by Application (2017-2022)
5.2.2 Global Thrombin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Thrombin Revenue Market Share by Application (2017-2028)
5.3 Global Thrombin Price by Application
5.3.1 Global Thrombin Price by Application (2017-2022)
5.3.2 Global Thrombin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Thrombin Market Size by Type
6.1.1 North America Thrombin Sales by Type (2017-2028)
6.1.2 North America Thrombin Revenue by Type (2017-2028)
6.2 North America Thrombin Market Size by Application
6.2.1 North America Thrombin Sales by Application (2017-2028)
6.2.2 North America Thrombin Revenue by Application (2017-2028)
6.3 North America Thrombin Market Size by Country
6.3.1 North America Thrombin Sales by Country (2017-2028)
6.3.2 North America Thrombin Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Thrombin Market Size by Type
7.1.1 Europe Thrombin Sales by Type (2017-2028)
7.1.2 Europe Thrombin Revenue by Type (2017-2028)
7.2 Europe Thrombin Market Size by Application
7.2.1 Europe Thrombin Sales by Application (2017-2028)
7.2.2 Europe Thrombin Revenue by Application (2017-2028)
7.3 Europe Thrombin Market Size by Country
7.3.1 Europe Thrombin Sales by Country (2017-2028)
7.3.2 Europe Thrombin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Thrombin Market Size by Type
8.1.1 Asia Pacific Thrombin Sales by Type (2017-2028)
8.1.2 Asia Pacific Thrombin Revenue by Type (2017-2028)
8.2 Asia Pacific Thrombin Market Size by Application
8.2.1 Asia Pacific Thrombin Sales by Application (2017-2028)
8.2.2 Asia Pacific Thrombin Revenue by Application (2017-2028)
8.3 Asia Pacific Thrombin Market Size by Region
8.3.1 Asia Pacific Thrombin Sales by Region (2017-2028)
8.3.2 Asia Pacific Thrombin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Thrombin Market Size by Type
9.1.1 Latin America Thrombin Sales by Type (2017-2028)
9.1.2 Latin America Thrombin Revenue by Type (2017-2028)
9.2 Latin America Thrombin Market Size by Application
9.2.1 Latin America Thrombin Sales by Application (2017-2028)
9.2.2 Latin America Thrombin Revenue by Application (2017-2028)
9.3 Latin America Thrombin Market Size by Country
9.3.1 Latin America Thrombin Sales by Country (2017-2028)
9.3.2 Latin America Thrombin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Thrombin Market Size by Type
10.1.1 Middle East and Africa Thrombin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Thrombin Revenue by Type (2017-2028)
10.2 Middle East and Africa Thrombin Market Size by Application
10.2.1 Middle East and Africa Thrombin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Thrombin Revenue by Application (2017-2028)
10.3 Middle East and Africa Thrombin Market Size by Country
10.3.1 Middle East and Africa Thrombin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Thrombin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Overview
11.1.3 Takeda Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Takeda Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 CSL
11.3.1 CSL Corporation Information
11.3.2 CSL Overview
11.3.3 CSL Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CSL Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Grifols
11.4.1 Grifols Corporation Information
11.4.2 Grifols Overview
11.4.3 Grifols Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Grifols Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Grifols Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Corporation Information
11.5.2 GE Healthcare Overview
11.5.3 GE Healthcare Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GE Healthcare Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GE Healthcare Recent Developments
11.6 Hualan Biological
11.6.1 Hualan Biological Corporation Information
11.6.2 Hualan Biological Overview
11.6.3 Hualan Biological Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Hualan Biological Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Biological Recent Developments
11.7 Haematologic Technologies Inc.
11.7.1 Haematologic Technologies Inc. Corporation Information
11.7.2 Haematologic Technologies Inc. Overview
11.7.3 Haematologic Technologies Inc. Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Haematologic Technologies Inc. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Haematologic Technologies Inc. Recent Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pfizer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Octapharma
11.9.1 Octapharma Corporation Information
11.9.2 Octapharma Overview
11.9.3 Octapharma Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Octapharma Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Octapharma Recent Developments
11.10 Omrix Biopharmaceuticals Ltd.
11.10.1 Omrix Biopharmaceuticals Ltd. Corporation Information
11.10.2 Omrix Biopharmaceuticals Ltd. Overview
11.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Omrix Biopharmaceuticals Ltd. Recent Developments
11.11 Shanghai RAAS
11.11.1 Shanghai RAAS Corporation Information
11.11.2 Shanghai RAAS Overview
11.11.3 Shanghai RAAS Thrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shanghai RAAS Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai RAAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Thrombin Industry Chain Analysis
12.2 Thrombin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Thrombin Production Mode & Process
12.4 Thrombin Sales and Marketing
12.4.1 Thrombin Sales Channels
12.4.2 Thrombin Distributors
12.5 Thrombin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Thrombin Industry Trends
13.2 Thrombin Market Drivers
13.3 Thrombin Market Challenges
13.4 Thrombin Market Restraints
14 Key Findings in The Global Thrombin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Thrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Powder Form
Table 3. Major Manufacturers of Solution Form
Table 4. Major Manufacturers of Pad Form
Table 5. Major Manufacturers of Spray Kits
Table 6. Major Manufacturers of Others
Table 7. Global Thrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Thrombin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Thrombin Sales by Region (2017-2022) & (MT)
Table 10. Global Thrombin Sales Market Share by Region (2017-2022)
Table 11. Global Thrombin Sales by Region (2023-2028) & (MT)
Table 12. Global Thrombin Sales Market Share by Region (2023-2028)
Table 13. Global Thrombin Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Thrombin Revenue Market Share by Region (2017-2022)
Table 15. Global Thrombin Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Thrombin Revenue Market Share by Region (2023-2028)
Table 17. Global Thrombin Sales by Manufacturers (2017-2022) & (MT)
Table 18. Global Thrombin Sales Share by Manufacturers (2017-2022)
Table 19. Global Thrombin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Thrombin Revenue Share by Manufacturers (2017-2022)
Table 21. Thrombin Price by Manufacturers (2017-2022) &(USD/Kg)
Table 22. Global Thrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Thrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thrombin as of 2021)
Table 24. Thrombin Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Thrombin Product Offered
Table 26. Date of Manufacturers Enter into Thrombin Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Thrombin Sales by Type (2017-2022) & (MT)
Table 29. Global Thrombin Sales by Type (2023-2028) & (MT)
Table 30. Global Thrombin Sales Share by Type (2017-2022)
Table 31. Global Thrombin Sales Share by Type (2023-2028)
Table 32. Global Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Thrombin Revenue Share by Type (2017-2022)
Table 35. Global Thrombin Revenue Share by Type (2023-2028)
Table 36. Thrombin Price by Type (2017-2022) & (USD/Kg)
Table 37. Global Thrombin Price Forecast by Type (2023-2028) & (USD/Kg)
Table 38. Global Thrombin Sales by Application (2017-2022) & (MT)
Table 39. Global Thrombin Sales by Application (2023-2028) & (MT)
Table 40. Global Thrombin Sales Share by Application (2017-2022)
Table 41. Global Thrombin Sales Share by Application (2023-2028)
Table 42. Global Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Thrombin Revenue Share by Application (2017-2022)
Table 45. Global Thrombin Revenue Share by Application (2023-2028)
Table 46. Thrombin Price by Application (2017-2022) & (USD/Kg)
Table 47. Global Thrombin Price Forecast by Application (2023-2028) & (USD/Kg)
Table 48. North America Thrombin Sales by Type (2017-2022) & (MT)
Table 49. North America Thrombin Sales by Type (2023-2028) & (MT)
Table 50. North America Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Thrombin Sales by Application (2017-2022) & (MT)
Table 53. North America Thrombin Sales by Application (2023-2028) & (MT)
Table 54. North America Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Thrombin Sales by Country (2017-2022) & (MT)
Table 57. North America Thrombin Sales by Country (2023-2028) & (MT)
Table 58. North America Thrombin Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Thrombin Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Thrombin Sales by Type (2017-2022) & (MT)
Table 61. Europe Thrombin Sales by Type (2023-2028) & (MT)
Table 62. Europe Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Thrombin Sales by Application (2017-2022) & (MT)
Table 65. Europe Thrombin Sales by Application (2023-2028) & (MT)
Table 66. Europe Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Thrombin Sales by Country (2017-2022) & (MT)
Table 69. Europe Thrombin Sales by Country (2023-2028) & (MT)
Table 70. Europe Thrombin Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Thrombin Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Thrombin Sales by Type (2017-2022) & (MT)
Table 73. Asia Pacific Thrombin Sales by Type (2023-2028) & (MT)
Table 74. Asia Pacific Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Thrombin Sales by Application (2017-2022) & (MT)
Table 77. Asia Pacific Thrombin Sales by Application (2023-2028) & (MT)
Table 78. Asia Pacific Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Thrombin Sales by Region (2017-2022) & (MT)
Table 81. Asia Pacific Thrombin Sales by Region (2023-2028) & (MT)
Table 82. Asia Pacific Thrombin Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Thrombin Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Thrombin Sales by Type (2017-2022) & (MT)
Table 85. Latin America Thrombin Sales by Type (2023-2028) & (MT)
Table 86. Latin America Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Thrombin Sales by Application (2017-2022) & (MT)
Table 89. Latin America Thrombin Sales by Application (2023-2028) & (MT)
Table 90. Latin America Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Thrombin Sales by Country (2017-2022) & (MT)
Table 93. Latin America Thrombin Sales by Country (2023-2028) & (MT)
Table 94. Latin America Thrombin Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Thrombin Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Thrombin Sales by Type (2017-2022) & (MT)
Table 97. Middle East and Africa Thrombin Sales by Type (2023-2028) & (MT)
Table 98. Middle East and Africa Thrombin Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Thrombin Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Thrombin Sales by Application (2017-2022) & (MT)
Table 101. Middle East and Africa Thrombin Sales by Application (2023-2028) & (MT)
Table 102. Middle East and Africa Thrombin Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Thrombin Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Thrombin Sales by Country (2017-2022) & (MT)
Table 105. Middle East and Africa Thrombin Sales by Country (2023-2028) & (MT)
Table 106. Middle East and Africa Thrombin Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Thrombin Revenue by Country (2023-2028) & (US$ Million)
Table 108. Takeda Corporation Information
Table 109. Takeda Description and Major Businesses
Table 110. Takeda Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 111. Takeda Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Takeda Recent Developments
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 116. Bayer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Bayer Recent Developments
Table 118. CSL Corporation Information
Table 119. CSL Description and Major Businesses
Table 120. CSL Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 121. CSL Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. CSL Recent Developments
Table 123. Grifols Corporation Information
Table 124. Grifols Description and Major Businesses
Table 125. Grifols Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 126. Grifols Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Grifols Recent Developments
Table 128. GE Healthcare Corporation Information
Table 129. GE Healthcare Description and Major Businesses
Table 130. GE Healthcare Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 131. GE Healthcare Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. GE Healthcare Recent Developments
Table 133. Hualan Biological Corporation Information
Table 134. Hualan Biological Description and Major Businesses
Table 135. Hualan Biological Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 136. Hualan Biological Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Hualan Biological Recent Developments
Table 138. Haematologic Technologies Inc. Corporation Information
Table 139. Haematologic Technologies Inc. Description and Major Businesses
Table 140. Haematologic Technologies Inc. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 141. Haematologic Technologies Inc. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Haematologic Technologies Inc. Recent Developments
Table 143. Pfizer Corporation Information
Table 144. Pfizer Description and Major Businesses
Table 145. Pfizer Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 146. Pfizer Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Pfizer Recent Developments
Table 148. Octapharma Corporation Information
Table 149. Octapharma Description and Major Businesses
Table 150. Octapharma Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 151. Octapharma Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Octapharma Recent Developments
Table 153. Omrix Biopharmaceuticals Ltd. Corporation Information
Table 154. Omrix Biopharmaceuticals Ltd. Description and Major Businesses
Table 155. Omrix Biopharmaceuticals Ltd. Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 156. Omrix Biopharmaceuticals Ltd. Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Omrix Biopharmaceuticals Ltd. Recent Developments
Table 158. Shanghai RAAS Corporation Information
Table 159. Shanghai RAAS Description and Major Businesses
Table 160. Shanghai RAAS Thrombin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 161. Shanghai RAAS Thrombin Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Shanghai RAAS Recent Developments
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Thrombin Distributors List
Table 166. Thrombin Customers List
Table 167. Thrombin Market Trends
Table 168. Thrombin Market Drivers
Table 169. Thrombin Market Challenges
Table 170. Thrombin Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombin Product Picture
Figure 3. Global Thrombin Market Share by Type in 2021 & 2028
Figure 3. Powder Form Product Picture
Figure 4. Solution Form Product Picture
Figure 5. Pad Form Product Picture
Figure 6. Spray Kits Product Picture
Figure 7. Others Product Picture
Figure 8. Global Thrombin Market Share by Application in 2021 & 2028
Figure 9. Hospitals
Figure 10. Diagnostics & Clinics
Figure 11. Academic and Research Institute
Figure 12. Thrombin Report Years Considered
Figure 13. Global Thrombin Sales 2017-2028 (MT)
Figure 14. Global Thrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Thrombin Revenue 2017-2028 (US$ Million)
Figure 16. Global Thrombin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Thrombin Sales Market Share by Region (2017-2022)
Figure 18. Global Thrombin Sales Market Share by Region (2023-2028)
Figure 19. North America Thrombin Sales YoY (2017-2028) & (MT)
Figure 20. North America Thrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Thrombin Sales YoY (2017-2028) & (MT)
Figure 22. Europe Thrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Thrombin Sales YoY (2017-2028) & (MT)
Figure 24. Asia-Pacific Thrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Thrombin Sales YoY (2017-2028) & (MT)
Figure 26. Latin America Thrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Thrombin Sales YoY (2017-2028) & (MT)
Figure 28. Middle East & Africa Thrombin Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Thrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Thrombin in the World: Market Share by Thrombin Revenue in 2021
Figure 31. Global Thrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Thrombin Sales Market Share by Type (2017-2028)
Figure 33. Global Thrombin Revenue Market Share by Type (2017-2028)
Figure 34. Global Thrombin Sales Market Share by Application (2017-2028)
Figure 35. Global Thrombin Revenue Market Share by Application (2017-2028)
Figure 36. North America Thrombin Sales Market Share by Type (2017-2028)
Figure 37. North America Thrombin Revenue Market Share by Type (2017-2028)
Figure 38. North America Thrombin Sales Market Share by Application (2017-2028)
Figure 39. North America Thrombin Revenue Market Share by Application (2017-2028)
Figure 40. North America Thrombin Sales Share by Country (2017-2028)
Figure 41. North America Thrombin Revenue Share by Country (2017-2028)
Figure 42. the United States Thrombin Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Thrombin Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Thrombin Sales Market Share by Type (2017-2028)
Figure 45. Europe Thrombin Revenue Market Share by Type (2017-2028)
Figure 46. Europe Thrombin Sales Market Share by Application (2017-2028)
Figure 47. Europe Thrombin Revenue Market Share by Application (2017-2028)
Figure 48. Europe Thrombin Sales Share by Country (2017-2028)
Figure 49. Europe Thrombin Revenue Share by Country (2017-2028)
Figure 50. Germany Thrombin Revenue (2017-2028) & (US$ Million)
Figure 51. France Thrombin Revenue (2017-2028) & (US$ Million)
Figure 52. UK Thrombin Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Thrombin Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Thrombin Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Thrombin Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Thrombin Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Thrombin Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Thrombin Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Thrombin Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Thrombin Revenue Share by Region (2017-2028)
Figure 61. China Thrombin Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Thrombin Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Thrombin Revenue (2017-2028) & (US$ Million)
Figure 64. India Thrombin Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Thrombin Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Thrombin Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Thrombin Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Thrombin Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Thrombin Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Thrombin Sales Market Share by Type (2017-2028)
Figure 71. Latin America Thrombin Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Thrombin Sales Market Share by Application (2017-2028)
Figure 73. Latin America Thrombin Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Thrombin Sales Share by Country (2017-2028)
Figure 75. Latin America Thrombin Revenue Share by Country (2017-2028)
Figure 76. Mexico Thrombin Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Thrombin Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Thrombin Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Thrombin Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Thrombin Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Thrombin Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Thrombin Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Thrombin Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Thrombin Revenue Share by Country (2017-2028)
Figure 85. Turkey Thrombin Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Thrombin Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Thrombin Revenue (2017-2028) & (US$ Million)
Figure 88. Thrombin Value Chain
Figure 89. Thrombin Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs